Been lurking in c/sideeffects for about 10 months and finally have something worth posting. Short version: week 67, 15mg, and triple agonist is the bit I still cannot…
u/discount_math_dm
The crypto discount is real. So is the loss of chargeback rights.
member · joined 22 Jan 2025
Overview — page 4 of 5
comment on [Question] triple agonist — what am I missing here in c/retatrutide · 108 points · 10 months ago
comment on genuine question about gas fees that I am slightly embarrassed to ask in c/cryptopay · 0 points · 10 months ago
comment on week 11 check-in — 31kg down, muscle cramps manageable, one thing confusing me in c/retatrutide · 205 points · 11 months ago
Research use material only, no human-use approval anywhere. Posts must describe what happened, not instruct strangers.
comment on [Discussion] the small molecule advice in here is 19 years out of date in c/orforglipron · 12 points · 11 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on [Results] 61 weeks on 1.7mg, full numbers, ask me anything boring in c/compounding · 51 points · 11 months ago
API source questions are on-topic and compounders dodging them is newsworthy
Disagree on that part. 99.0% and 98.9% on the same vial is normal.
comment on telehealth is the most under-discussed thing in c/progresspics in c/compounding · 31 points · 11 months ago
Did they tell you their API source or dodge the question?
comment on [Question] Ireland — has anyone got a straight answer on API source in c/compounding · 211 points · 1 year ago
This is correct. The shortage list does expire and the rules change.
comment on [Meta] the SURMOUNT rule is doing its job and people should stop complaining in c/tirzepatide · 235 points · 1 year ago
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
comment on [Discussion] the escrow advice in here is 2 years out of date in c/cryptopay · 1 points · 1 year ago
no price talk, no tickers, no investment discussion
comment on week 91 check-in — 6kg down, constipation manageable, one thing confusing me in c/compounding · 4 points · 1 year ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on [PSA] escrow is not what most of this community thinks it is in c/cryptopay · -20 points · 1 year ago
Not convinced. The evidence does not support that reading.
comment on [Lab] split one vial across Medutest and Janoshik — 96.2% and 99.2% in c/retatrutide · 75 points · 1 year ago
nobody should be giving this to anyone without extensive monitoring
comment on orforglipron vs ATTAIN — genuinely asking which matters more in c/orforglipron · 6 points · 1 year ago
Crossposting this to c/survodutide because the people who need it are not reading this community.
comment on reading 15mg threads from 2024 and half of it aged badly in c/tirzepatide · 4 points · 1 year ago
the dual agonism hits different and that is why people describe it differently
comment on Germany: SURMOUNT, and what it actually costs here in c/tirzepatide · 645 points · 1 year ago
The confident tone is doing a lot of work that the evidence is not.
comment on [Question] USDC — what am I missing here in c/cryptopay · 11 points · 1 year ago
the 11% discount versus 18% network fees
comment on [Discussion] can we stop arguing about compounding until somebody posts a number in c/compounding · -3 points · 1 year ago
Yeah, 503A and 503B are different regulatory animals.
comment on [Results] 37 weeks, 16kg, and phase 2 was the hard part in c/retatrutide · 1 points · 1 year ago
This is correct. Triple agonism is genuinely different.
comment on compounding is the most under-discussed thing in c/hplc in c/compounding · 5 points · 1 year ago
the shortage list is temporary, it ends and compounding becomes illegal again